RecruitingNCT07516496
Metabolic Phenotyping in vEDS
Studying Acquired partial lipodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Intervention
- No intervention, observational(other)
- Enrollment
- 15 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2026 – 2031
Study locations (1)
- Translational Research Facility, Cambridge Clinical Research Centre (CCRC), Keith Day Road, Cambridge, CB2 0QQ., Cambridge, United Kingdom
Collaborators
University of Cambridge
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07516496 on ClinicalTrials.govOther trials for Acquired partial lipodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT06484868Open-label Study to Evaluate Metreleptin in Patients With Partial LipodystrophyAmryt Pharma
- RECRUITINGNCT05996536Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- RECRUITINGPHASE2NCT05470504Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin ResistanceNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- ACTIVE NOT RECRUITINGPHASE3NCT05164341Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PLAmryt Pharma
- RECRUITINGNANCT03900286Low Energy Diet and Familial Partial LipodystrophyCambridge University Hospitals NHS Foundation Trust
- ACTIVE NOT RECRUITINGPHASE2NCT02262806Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)